138 related articles for article (PubMed ID: 31828595)
1. Multiple heterogeneous bone invasions of B lymphoblastic lymphoma with the TCF3/PBX1 fusion gene: a case report.
Okura E; Saito S; Natsume T; Morita D; Tanaka M; Kiyokawa N; Nakazawa Y
Int J Hematol; 2020 Feb; 111(2):163-165. PubMed ID: 31828595
[No Abstract] [Full Text] [Related]
2. Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1.
Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Mori T; Yoshida M; Yoshida K; Kohri M; Ishihara T; Yasue S; Imamura T; Endo M; Miyamoto S; Ohki K; Sanada M; Kiyokawa N; Ogawa S; Yoshioka T; Hata K; Takagi M; Kato M
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1559. PubMed ID: 34553842
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children.
Lee SHR; Qian M; Yang W; Diedrich JD; Raetz E; Yang W; Dong Q; Devidas M; Pei D; Yeoh A; Cheng C; Pui CH; Evans WE; Mullighan CG; Hunger SP; Savic D; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2021 Jul; 113(7):933-937. PubMed ID: 32882024
[TBL] [Abstract][Full Text] [Related]
4. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
Rowsey RA; Smoley SA; Williamson CM; Vasmatzis G; Smadbeck JB; Ning Y; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
Blood Cancer J; 2019 Oct; 9(10):81. PubMed ID: 31575852
[TBL] [Abstract][Full Text] [Related]
5. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
[TBL] [Abstract][Full Text] [Related]
8. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in
Gutierrez-Camino A; Caron M; Richer C; Fuchs C; Illarregi U; Poncelet L; St-Onge P; Bataille AR; Tremblay-Dauphinais P; Lopez-Lopez E; Camos M; Ramirez-Orellana M; Astigarraga I; Lécuyer É; Bourque G; Martin-Guerrero I; Sinnett D
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338754
[TBL] [Abstract][Full Text] [Related]
9. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
[TBL] [Abstract][Full Text] [Related]
10. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
[TBL] [Abstract][Full Text] [Related]
11. SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.
Lin CH; Wong SH; Kurzer JH; Schneidawind C; Wei MC; Duque-Afonso J; Jeong J; Feng X; Cleary ML
Cell Rep; 2018 Apr; 23(4):1166-1177. PubMed ID: 29694893
[TBL] [Abstract][Full Text] [Related]
12. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of B-cell acute lymphoblastic leukemia with TCF/PBX1 fusion gene and ovarian involvement at diagnosis: Two case reports and review of the literature.
Vinti L; Del Baldo G; Lodi M; Stocchi F; Cefalo MG; Pagliara D
Pediatr Blood Cancer; 2022 Jan; 69(1):e29299. PubMed ID: 34411424
[No Abstract] [Full Text] [Related]
14. Homozygous transcription factor 3 gene (TCF3) mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia.
Ben-Ali M; Yang J; Chan KW; Ben-Mustapha I; Mekki N; Benabdesselem C; Mellouli F; Bejaoui M; Yang W; Aissaoui L; Lau YL; Barbouche MR
J Allergy Clin Immunol; 2017 Oct; 140(4):1191-1194.e4. PubMed ID: 28532655
[No Abstract] [Full Text] [Related]
15. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
Kager L; Lion T; Attarbaschi A; Koenig M; Strehl S; Haas OA; Dworzak MN; Schrappe M; Gadner H; Mann G;
Haematologica; 2007 Nov; 92(11):1561-4. PubMed ID: 18024406
[TBL] [Abstract][Full Text] [Related]
16. Extended vincristine and dexamethasone pulse therapy may not be necessary for children with TCF3-PBX1 positive acute lymphoblastic leukaemia.
Wan Y; Zhang H; Zhang L; Cai J; Yu J; Hu S; Fang Y; Gao J; Jiang H; Yang M; Liang C; Jin R; Tian X; Ju X; Hu Q; Jiang H; Li H; Wang N; Sun L; Leung AWK; Wu X; Wang J; Li CK; Yang J; Tang J; Shen S; Zhai X; Pui CH; Zhu X
Br J Haematol; 2022 Nov; 199(4):587-596. PubMed ID: 36114009
[TBL] [Abstract][Full Text] [Related]
17. Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.
Eldfors S; Kuusanmäki H; Kontro M; Majumder MM; Parsons A; Edgren H; Pemovska T; Kallioniemi O; Wennerberg K; Gökbuget N; Burmeister T; Porkka K; Heckman CA
Leukemia; 2017 Jan; 31(1):51-57. PubMed ID: 27461063
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19).
Shirasaki R; Tashiro H; Oka Y; Sugao T; Yamamoto T; Yoshimi M; Akiyama N; Kawasugi K; Shirafuji N
Int J Hematol; 2011 Aug; 94(2):203-208. PubMed ID: 21732038
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
Gabriel AS; Lafta FM; Schwalbe EC; Nakjang S; Cockell SJ; Iliasova A; Enshaei A; Schwab C; Rand V; Clifford SC; Kinsey SE; Mitchell CD; Vora A; Harrison CJ; Moorman AV; Strathdee G
Epigenetics; 2015; 10(8):717-26. PubMed ID: 26237075
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
